Amendment to 4.75% Senior Convertible NotesAmendment to 4.75% Senior Convertible Notes • June 18th, 2007 • Novavax Inc • Biological products, (no disgnostic substances)
This amendment agreement (this “Amendment”) dated June 15, 2007 to the 4.75% senior convertible notes issued pursuant to the Purchase Agreement (as defined below) (the “Notes”) is made by and between Novavax Inc., a Delaware corporation (the “Company”) and Smithfield Fiduciary LLC (the “Investor”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to such terms in the Notes.
